Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 5, 2025 - The FDA approved Azurity Pharmaceuticals’ Xifyrm (meloxicam), for use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID analgesics.
Download PDF
Return to publications
